Australia's CSL falls to over 8-yr low as Pentagon ends flu vaccine mandate

CSL

24/04/2026 04:01

** Shares of CSL CSL.AX fall as much as 1% to A$127.75, their lowest level since August 31, 2017

** The biotech giant is down over 6% for the week, logging its worst week since mid-February

** Slide after Pentagon's decision to scrap its flu vaccine mandate, marking a reversal from a long-standing requirement and raising concerns about demand from a key institutional buyer

** Stock down 25.7% YTD

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))